{"id":32429,"date":"2025-04-25T16:45:15","date_gmt":"2025-04-25T08:45:15","guid":{"rendered":"https:\/\/flcube.com\/?p=32429"},"modified":"2025-04-25T16:45:16","modified_gmt":"2025-04-25T08:45:16","slug":"merck-kgaa-nears-completion-of-3-5-billion-acquisition-of-springworks-therapeutics","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=32429","title":{"rendered":"Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics"},"content":{"rendered":"\n

German pharmaceutical major Merck KGaA\u00a0(ETR: MRK<\/a>) is reportedly nearing the completion of its acquisition of US-based SpringWorks Therapeutics for USD 3.5 billion, according to the Wall Street Journal. SpringWorks’ stock price increased by 9.03% to USD 44.93 on Thursday afternoon following the announcement. Insiders indicate that the companies have agreed on a price close to USD 47 per share, with the deal expected to be finalized as early as next Monday if discussions proceed smoothly.<\/p>\n\n\n\n

SpringWorks’ Portfolio and Performance<\/strong>
SpringWorks’ first drug, Ogsiveo (nirogacestat), an oral \u03b3 secretase inhibitor approved for desmoid tumors in the US, has been a significant contributor to the company\u2019s revenue. In 2024, SpringWorks generated USD 191 million in revenues, with USD 172 million attributed to Ogsiveo. Earlier this year, the company also received US marketing approval for Gomekli (mirdametinib), an oral MEK inhibitor for the treatment of type 1 neurofibromatosis (NF1) and symptomatic plexiform neurofibromatosis (PN) that cannot be completely resected.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

German pharmaceutical major Merck KGaA\u00a0(ETR: MRK) is reportedly nearing the completion of its acquisition of…<\/p>\n","protected":false},"author":1,"featured_media":32430,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[30,1147,120,2917],"class_list":["post-32429","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-biotech","tag-etr-mrk","tag-merck","tag-springworks-therapeutics"],"yoast_head":"\nMerck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"German pharmaceutical major Merck KGaA\u00a0(ETR: MRK) is reportedly nearing the completion of its acquisition of US-based SpringWorks Therapeutics for USD 3.5 billion, according to the Wall Street Journal. SpringWorks' stock price increased by 9.03% to USD 44.93 on Thursday afternoon following the announcement. Insiders indicate that the companies have agreed on a price close to USD 47 per share, with the deal expected to be finalized as early as next Monday if discussions proceed smoothly.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=32429\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics\" \/>\n<meta property=\"og:description\" content=\"German pharmaceutical major Merck KGaA\u00a0(ETR: MRK) is reportedly nearing the completion of its acquisition of US-based SpringWorks Therapeutics for USD 3.5 billion, according to the Wall Street Journal. SpringWorks' stock price increased by 9.03% to USD 44.93 on Thursday afternoon following the announcement. Insiders indicate that the companies have agreed on a price close to USD 47 per share, with the deal expected to be finalized as early as next Monday if discussions proceed smoothly.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=32429\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-25T08:45:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-25T08:45:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2505.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32429#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32429\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics\",\"datePublished\":\"2025-04-25T08:45:15+00:00\",\"dateModified\":\"2025-04-25T08:45:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32429\"},\"wordCount\":163,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32429#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2505.webp\",\"keywords\":[\"Biotech\",\"ETR: MRK\",\"Merck\",\"SpringWorks Therapeutics\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=32429#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32429\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=32429\",\"name\":\"Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32429#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32429#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2505.webp\",\"datePublished\":\"2025-04-25T08:45:15+00:00\",\"dateModified\":\"2025-04-25T08:45:16+00:00\",\"description\":\"German pharmaceutical major Merck KGaA\u00a0(ETR: MRK) is reportedly nearing the completion of its acquisition of US-based SpringWorks Therapeutics for USD 3.5 billion, according to the Wall Street Journal. SpringWorks' stock price increased by 9.03% to USD 44.93 on Thursday afternoon following the announcement. Insiders indicate that the companies have agreed on a price close to USD 47 per share, with the deal expected to be finalized as early as next Monday if discussions proceed smoothly.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32429#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=32429\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32429#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2505.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2505.webp\",\"width\":1080,\"height\":608,\"caption\":\"Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32429#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics - Insight, China's Pharmaceutical Industry","description":"German pharmaceutical major Merck KGaA\u00a0(ETR: MRK) is reportedly nearing the completion of its acquisition of US-based SpringWorks Therapeutics for USD 3.5 billion, according to the Wall Street Journal. SpringWorks' stock price increased by 9.03% to USD 44.93 on Thursday afternoon following the announcement. Insiders indicate that the companies have agreed on a price close to USD 47 per share, with the deal expected to be finalized as early as next Monday if discussions proceed smoothly.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=32429","og_locale":"en_US","og_type":"article","og_title":"Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics","og_description":"German pharmaceutical major Merck KGaA\u00a0(ETR: MRK) is reportedly nearing the completion of its acquisition of US-based SpringWorks Therapeutics for USD 3.5 billion, according to the Wall Street Journal. SpringWorks' stock price increased by 9.03% to USD 44.93 on Thursday afternoon following the announcement. Insiders indicate that the companies have agreed on a price close to USD 47 per share, with the deal expected to be finalized as early as next Monday if discussions proceed smoothly.","og_url":"https:\/\/flcube.com\/?p=32429","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-04-25T08:45:15+00:00","article_modified_time":"2025-04-25T08:45:16+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2505.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=32429#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=32429"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics","datePublished":"2025-04-25T08:45:15+00:00","dateModified":"2025-04-25T08:45:16+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=32429"},"wordCount":163,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=32429#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2505.webp","keywords":["Biotech","ETR: MRK","Merck","SpringWorks Therapeutics"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=32429#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=32429","url":"https:\/\/flcube.com\/?p=32429","name":"Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=32429#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=32429#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2505.webp","datePublished":"2025-04-25T08:45:15+00:00","dateModified":"2025-04-25T08:45:16+00:00","description":"German pharmaceutical major Merck KGaA\u00a0(ETR: MRK) is reportedly nearing the completion of its acquisition of US-based SpringWorks Therapeutics for USD 3.5 billion, according to the Wall Street Journal. SpringWorks' stock price increased by 9.03% to USD 44.93 on Thursday afternoon following the announcement. Insiders indicate that the companies have agreed on a price close to USD 47 per share, with the deal expected to be finalized as early as next Monday if discussions proceed smoothly.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=32429#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=32429"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=32429#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2505.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2505.webp","width":1080,"height":608,"caption":"Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=32429#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2505.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=32429"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32429\/revisions"}],"predecessor-version":[{"id":32431,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32429\/revisions\/32431"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/32430"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=32429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=32429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=32429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}